Core Viewpoint - Tsinghua Tongfang Pharmaceutical (启迪药业) is undergoing a significant change in its ownership structure due to a judicial auction of shares held by its controlling shareholder, Tsinghua Tongfang Technology Service Co., Ltd. (启迪科服), which will result in a new major shareholder, Hunan Sailuxian Management Consulting Partnership (湖南赛乐仙) [1] Group 1 - On August 6, Tsinghua Tongfang Pharmaceutical received a court ruling from the Beijing Financial Court regarding the transfer of 58.607 million shares to Hunan Sailuxian [1] - The share transfer represents 24.47% of Tsinghua Tongfang Pharmaceutical's total shares, indicating a substantial shift in ownership [1] - Following this transfer, Tsinghua Tongfang Technology Service Co., Ltd. will no longer hold any shares in Tsinghua Tongfang Pharmaceutical, leading to a change in control and potential impacts on corporate governance [1]
启迪药业控制权拟发生变更